High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Lim, B., Ueno, N.T., Litton, J.K., Ferrarotto, R., Chang, J.T., Moulder, S.L., Lin, S.-Y.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Ueno, N.T., Ferrarotto, R., Chang, J.T., Lin, S.-Y.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al
McGrail, D.J., Pilié, P.G., Rashid, N.U., Voorwerk, L., Slagter, M., Kok, M., Jonasch, E., Khasraw, M., Heimberger, A.B., Ueno, N.T., Ferrarotto, R., Chang, J.T., Lin, S.-Y.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
77P Clinical characteristics and therapeutic implications of PALB2 variants in patients with advanced solid tumors
Gheeya, J.S., Goswamy, R., Garmezy, B., Pilie, P.G., Wang, W., Lee, S., Javle, M., Rodon, J., Mills Shaw, K.R., Meric-Bernstam, F., Yap, T.A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
669P Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
Hahn, A.W., Tidwell, R.S., Surasi, D.S., Msaouel, P., Efstathiou, E., Zurita-Saavedra, A.J., Tu, S-M., McQuade, J.L., Fogelman, D., Starbuck, M.W., Subudhi, S.K., Corn, P., Pilie, P.G., Aparicio, A., Logothetis, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations
Ngoi, N., Pilie, P.G., Piha-Paul, S.A., Dumbrava, E.E., Fu, S., Hong, D.S., Karp, D.D., Naing, A., Pant, S., Rodon Ahnert, J., Subbiah, V., Tsimberidou, A.M., Salguero, C., Brown, C.V., Hoadley, W.E., Johnson, A., Yuan, Y., Westin, S.N., Meric-Bernstam, F., Yap, T.A.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article